相关实验视频

Updated: Sep 20, 2025

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer
10:36

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer

Published on: March 17, 2016

10.6K

雌激素受体低阳性乳腺癌:历史观点和最近的进展

Huina Zhang1, Madhurya Ramineni1, Xiaoxian Li2

  • 1Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY, 14624, USA.

Human pathology
|May 29, 2025
PubMed
概括

低ER阳性乳腺癌 (1-10%的ER染色) 提出了独特的挑战. 本综述探讨了它的生物学,病理学和临床影响,强调了这种侵略性亚型的治疗不确定性.

关键词:
乳腺癌是什么? 乳腺癌是什么在ER-Low中,阳性很低.雌激素受体的受体是什么免疫组织化学 免疫组织化学体结合试验法 体结合试验法

更多相关视频

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material11:12

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Published on: August 1, 2018

8.1K
Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer07:45

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer

Published on: May 18, 2020

6.3K

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
1.7K